Abstract
Although it has been more than 20 yr since its discovery, the ras family of genes has not yet lost its impact on basic and clinical oncology. These genes remain central to the field of molecular oncology as tools for investigating carcinogenesis and oncogenic signaling, as powerful biomarkers for the identification of those who have or are at high risk of developing cancer, and as oncogene targets for the design and development of new chemotherapeutic drugs. Mutational activation of the K-RAS proto-oncogene is an early event in the development and progression of the colorectal, pancreatic, and lung cancers that are the major causes of cancer death in the world. The presence of point mutational “hot spots” at sites necessary for the activation of this proto-oncogene has led to the development of a number of highly sensitive PCR-based methods that are feasible for the early detection of K-RAS oncogene mutations in the clinical setting. In light of these facts, mutation at the K-RAS oncogene has the potential to serve as a useful biomarker in the early diagnosis and risk assessment of cancers with oncogenic Ras signaling. This chapter describes a highly sensitive method for detecting mutant K-RAS, enriched PCR, and its application to early detection of this oncogene in preneoplastic and early neoplastic lesions of the colon and rectum.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Karp, J. E. and Broder, S. (1995) Molecular foundations of cancer: new targets for intervention. Nat. Med. 1, 309–320.
Ponder B. A. J. (2001) Cancer genetics. Nature 411, 336–341.
Fearon, E. R. (1997) Human cancer syndromes: clues to the origin and nature of cancer. Science 278, 1043–1050.
Blume-Jensen, P. and Hunter, T. (2001) Oncogenic kinase signaling. Nature 411, 355–365.
Bos, J. L. (1989) ras oncogenes in human cancer: a review. Cancer Res. 49, 4682–4689.
Kiaris, H. and Spandidos, D. A. (1995) Mutations of ras genes in human tumors. Int. J. Oncol. 7, 413–421.
Minamoto, T., Mai, M., and Ronai, Z. (2000) K-RAS mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers—a review. Cancer Detect. Prev. 4, 1–12.
van Mansfeld, A. D. M. and Bos, J. L. (1992) PCR-based approaches for detection of mutated ras genes. PCR Methods Appl. 1, 211–216.
Ronai, Z. and Yakubovskaya, M. (1995) PCR in clinical diagnosis. J. Clin. Lab. Anal. 9, 269–283.
Kahn, S. M., Jiang, W., Culbertson, T. A., et al. (1991) Rapid and sensitive nonradioactive detection of mutant K-RAS genes via ‘enriched’ PCR amplification. Oncogene 6, 1079–1083.
Jiang, W., Kahn, S., Guillem, J., Lu, S., and Weinstein, I. B. (1989) Rapid detection of ras oncogenes in human tissues: applications to colon, esophageal, and gastric cancer. Oncogene 4, 923–928.
Minamoto, T., Ronai, Z., Yamashita, N., et al. (1994) Detection of Ki-RAS mutation in non-neoplastic mucosa of Japanese patients with colorectal cancers. Int. J. Oncol. 4, 397–401.
Chung, D. C. (2000) The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 119, 864–865.
Minamoto, T. and Ronai, Z. (2001) Gene mutation as a target for early detection in cancer diagnosis. Crit. Rev. Oncol. Hematol. 40, 195–213.
Ronai, Z., Luo, F. C., Gradia, S., Hart, W. J., and Butler, R. (1994) Detection of K-RAS mutation in normal and malignant colonic tissues by an enriched PCR method. Int. J. Oncol. 4, 391–396.
Minamoto, T., Yamashita, N., Ochiai, A., et al. (1995) Mutant K-RAS in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal cancer patients. Cancer 75, 1520–1526.
Ronai, Z., Minamoto, T., Butler, R., et al. (1995) Sampling method as a key factor in identifying K-RAS oncogene mutations in preneoplastic colorectal lesions. Cancer Detect. Prev. 19, 512–517.
Minamoto, T., Esumi, H., Ochiai, A., et al. (1997) Combined analysis of microsatellite instability and K-RAS mutation increases detection incidence of normal samples from colorectal cancer patients. Clin. Cancer Res. 3, 1413–1417.
Tobi, M., Luo, F.-C, and Ronai, Z. (1994) Detection of K-RAS mutation in colonic effluent samples from patients without evidence of colorectal carcinoma. J. Natl. Cancer Inst. 86, 1007–1010.
Zhang, B., Ougolkov, A., Yamashita, K., Takahashi, Y., Mai, M., and Minamoto, T. (2003) β-catenin and ras oncogenes detect most human colorectal cancers. Clin. Cancer Res. 3, 3073–3079.
Pretlow, T. P. (1995) Aberrant crypt foci and K-RAS mutations: earliest recognized players or innocent bystanders in colon carcinogenesis? Gastroenterology 108, 600–603.
Yamashita, N., Minamoto, T., Ochiai, A., Onda, M., and Esumi, H. (1995) Frequent and characteristic K-RAS activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 108, 434–440.
Takayama, T., Katsuki, S., Takahashi, Y., et al. (1998) Aberrant crypt foci of the colon as precursors of adenoma and cancer. N. Engl. J. Med. 339, 1277–1284.
Otori, K., Sugiyama, K., Hasebe, T., Fukushima, S., and Esumi, H. (1995) Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res. 55, 4743–4746.
Konstantakos, A. K., Siu, I.-M., Pretlow, T. G., Stellato, T. A., and Pretlow, T. P. (1996) Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer. Gastroenterology 111, 772–777.
Pretlow, T. P., Brasitus, T. A., Fulton, N. C., Cheyer, C., and Kaplan, E. L. (1993) K-RAS mutation in putative preneoplastic lesions in human colon. J. Natl. Cancer Inst. 85, 2004–2007.
Takayama, T., Ohi, M., Hayashi, T., et al. (2001) Analysis of K-RAS, APC, and β-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 121, 599–611.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Isolation of high-molecular-weight DNA from mammalian cells, in Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 9.14–9.23.
Moore, D. D. and Strauss, W. M. (1995) Preparation of genomic DNA from mammalian tissue, in Short Protocols in Molecular Biology, 3rd ed. (Ausubel, F., Brent, R., Kingston, R. E., et al., eds.), Wiley, Hoboken, NJ, pp. 2–8.
Wolff, R. and Gemmill, R. (1997) DNA from mammalian sources, in Genome Analysis: A Laboratory Manual, vol. 1 (Birren, B., Green, E. D., Klapholz, S., Myers, R. M., and Roskams, J., eds.), Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 4–16.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Extraction with phenol∶chloroform, in Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Plainview, NY, pp. E.3–E.4.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Polyacrylamide gel electrophoresis, in Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 6.36–6.59.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Minamoto, T. (2005). Detection and Characterization of Oncogene Mutations in Preneoplastic and Early Neoplastic Lesions. In: Keohavong, P., Grant, S.G. (eds) Molecular Toxicology Protocols. Methods in Molecular Biology™, vol 291. Humana Press. https://doi.org/10.1385/1-59259-840-4:263
Download citation
DOI: https://doi.org/10.1385/1-59259-840-4:263
Publisher Name: Humana Press
Print ISBN: 978-1-58829-084-7
Online ISBN: 978-1-59259-840-3
eBook Packages: Springer Protocols